GLP-1 and Pregnancy: Safety, Risks, and What to Do

GLP-1 medications are not recommended during pregnancy. This is one of the clearest guidance statements in GLP-1 prescribing — and one that every patient of childbearing age should understand before starting treatment. But there is nuance worth exploring: what to do if you conceive while on treatment, how GLP-1 can indirectly support fertility, and what contraception planning looks like in practice.

Current evidence on GLP-1 and pregnancy safety

There are no large randomised controlled trials in pregnant humans for GLP-1 medications — this is expected, as it would be ethically untenable to expose pregnant women to experimental medication. What we have are animal studies: in several species, GLP-1 receptor agonists at doses comparable to human therapeutic doses showed adverse fetal outcomes including growth restriction and structural abnormalities.

These animal findings do not mean the same will happen in humans. But the precautionary principle is clear: without reassuring human safety data, and given the plausibility of harm suggested by animal data, GLP-1 should be discontinued before conception. All major prescribing guidelines globally — including those in Malaysia — take this position.

What to do if you conceive while on GLP-1

If you discover you are pregnant while on GLP-1, stop the medication immediately and contact your obstetrician. Do not wait for your next check-in. The risk is primarily in early pregnancy during organogenesis (the first trimester), so prompt discontinuation minimises exposure. Your obstetrician will arrange appropriate monitoring.

GLP-1 and PCOS: indirectly supporting fertility

Here is an important nuance: while GLP-1 is not safe during pregnancy itself, it can indirectly improve fertility for women with PCOS (polycystic ovary syndrome). PCOS is the most common cause of anovulatory infertility in women of reproductive age, and weight and insulin resistance are central drivers of the hormonal disruption that causes it. GLP-1 addresses both: weight loss restores ovulatory cycles in many women with PCOS, and the medication's direct insulin-sensitising effects compound this benefit.

Contraception planning on GLP-1

Because GLP-1 can indirectly restore ovulation in women with PCOS — sometimes unexpectedly — effective contraception is important for any patient on GLP-1 treatment who does not wish to become pregnant. This is particularly relevant for women who previously assumed they were infertile due to PCOS-related anovulation. Discuss your contraception plan with your Seimbang doctor at the start of treatment.

When to stop GLP-1 before trying to conceive

Current guidance recommends stopping GLP-1 medication before conception. Given semaglutide's half-life of approximately one week, a washout period of at least 4–8 weeks before attempting to conceive is generally recommended — though practice varies by clinician and specific medication. Discuss your family planning timeline with your Seimbang doctor so we can plan a structured, timed taper.

Frequently Asked Questions